American Journal of Clinical Oncology-Cancer Clinical Trials

Papers
(The H4-Index of American Journal of Clinical Oncology-Cancer Clinical Trials is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Efficacy and Safety of Pegylated Filgrastim as Primary Prophylaxis Following Pediatric Dose-intensive Chemotherapy62
Validation of Spanish-Language Surveys Utilized for the Navigator-Assisted Hypofractionation (NAVAH) Program to Aid Hispanic-American Breast Cancer Patients24
Death From Infection Among Patients Living With Cancer24
The Prognostic Significance of the Depth of Cervical Stromal Invasion in Women With FIGO Stage II Uterine Endometrioid Carcinoma21
The Landscape of Clinical Trials for Claudin18.2-Positive Gastric Cancer19
Pharmacokinetics-Pharmacodynamics Modeling and Evaluation of Tumor Response to Bortezomib Proteasome Inhibitor in Waldenstrom Macroglobulinemia19
Does Examined Lymph Node Count Influence Survival in Surgically Resected Early‑stage Pulmonary Typical Carcinoid Tumors?16
Nomogram Predicting Grade ≥2 Acute Radiation Enteritis in Patients With Cervical Cancer Receiving Concurrent Chemoradiotherapy15
Clinical Outcomes and Safety Profile of Adagrasib in KRAS G12C-Mutated Solid Tumors14
Endpoint Governance and Reporting Transparency in Biomarker-Guided Oncology Trials14
The Impact of Patient, Disease, and Social Determinants of Health on Receipt of Nonoperative Management for Patients With Rectal Adenocarcinoma13
Third-line Treatment for Metastatic Triple-negative Breast Cancer12
Efficacy and Prognostic Factors of Immune Checkpoint Inhibitors in the Treatment of Advanced Non-small Cell Lung Cancer12
0.10422992706299